Subject: TRTC Announces Record Numbers Now We Know Why the Stock is on Fire

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
TRTC Announces Record Numbers Now We Know Why the Stock is on Fire
Hot Stock to WatchHot Stock to Watch

Company: Terra Tech Corp. (OTCQX: TRTC)


Price: 0.262

Change (%): - 0.031 (10.58)

Volume: 15,820,101
TRTC Chart

Terra Tech Corp. Reports Record Revenues for Year End 2015

41% revenue growth year-over-year for full year 2015

44% revenue growth quarter-over-quarter for Q4 2015

NEWPORT BEACH, Calif., March 29, 2016 /PRNewswire/ - Terra Tech Corp. (OTCQX: TRTC) (“Terra Tech” or the “Company”), a vertically integrated cannabis-focused agriculture company, today announced its financial results for the year ending December 31, 2015.

“After a year of progress in the cannabis industry, including the implementation of California’s Marijuana Regulation and Safety Act, we entered 2016 with continued optimism about what the future holds for Terra Tech,” commented Derek Peterson, CEO of Terra Tech Corp. “During 2015 we took a number of important steps to position the Company for growth as the industry continues to reduce barriers to the supply of medical cannabis. In particular, we launched IVXX, our proprietary medical cannabis brand, which positions Terra Tech as a leading provider of high quality cannabis products and propelled us to the forefront of innovation in the industry. The launch of IVXX is particularly exciting for the Company given the rate of growth that we are seeing in the medical cannabis markets and the rapidly evolving regulatory landscape, which is becoming increasingly friendly to patients looking to alleviate their symptoms with responsible use of medical cannabis products. Although we are in the early days of marketing IVXX products, we are encouraged by the traction generated to date and are pleased to report that IVXX-branded products are now being sold in approximately 200 dispensaries across California and Nevada.”

“We also recently announced the pending acquisition of Blum Oakland, a medical cannabis dispensary in California, which will expand our reach into retail. Now that we touch every phase in the cannabis life cycle we are confident that we have a strong platform to rapidly expand our commercialization efforts and establish the IVXX brand as a market leader. As part of our strategy to expand our retail presence, in 2015 we secured eight permits to open Blum cannabis dispensaries in Nevada, the first of which is due to open next month. By expanding into Nevada we are opening up our total addressable market significantly as Nevada is the only state to recognize the patient-status of non-residents.”

“Edible Garden also saw improved results and its organic products are now sold in 1800 retailers across 18 states. We worked to expand our selection of organic produce during the year and to gain recognition as providers of high quality produce. We have been granted the Global Food Safety Initiative (GFSI) certification, among other certifications, as evidence of the quality of our products. Our initiatives to grow the Edible Garden business led to a 30% increase in sales in this segment, year over year.”

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks